nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

01.07.2008 | Review

Pentavalent human-bovine (WC3) reassortant rotavirus vaccine in special populations: a review of data from the Rotavirus Efficacy and Safety Trial

verfasst von: M. Van der Wielen, P. Van Damme

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Rotavirus gastroenteritis is a disease that causes significant morbidity and mortality worldwide in infants and children. The recent availability of efficacious rotavirus vaccines with favorable safety profiles has prompted medical agencies around the world to register the vaccines and countries and regions to recommend universal vaccination of healthy infants to prevent the serious health and economic consequences of rotavirus illness in children. Premature infants can be especially vulnerable to severe rotavirus infections, which may lead to serious outcomes. The clinical efficacy and safety of the pentavalent human-bovine rotavirus vaccine (PRV, RotaTeq®, Merck, Whitehouse Station, NJ, USA) in healthy infants has been evaluated in the large phase III Rotavirus Efficacy and Safety Trial (REST). Preterm (N = 2,070) and exclusively breastfed infants (N = 1,566) were included in this study. The efficacy and safety of PRV in premature infants and in breastfed infants from the REST database are reviewed along with guidelines from national medical organizations for the use of PRV in these populations. Based on these data from the REST study, premature infants receive the same protection from PRV compared with nonpremature infants, without additional safety risk. Similarly, breastfed and nonbreastfed infants are equally protected from severe consequences of rotavirus gastroenteritis.

Fischer TK, Bresee JS, Glass RI (2004) Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine 22(Suppl 1):S49–S54PubMedCrossRef

Chen SM, Ni YH, Chen HL, Chang MH (2006) Microbial etiology of acute gastroenteritis in hospitalized children in Taiwan. J Formos Med Assoc 105:964–970PubMed

Colomba C, De Grazia S, Giammanco GM, Saporito L, Scarlata F, Titone L, Arista S (2006) Viral gastroenteritis in children hospitalized in Sicily, Italy. Eur J Clin Microbiol Infect Dis 25:570–575PubMedCrossRef

Bresee JS, Glass RI, Ivanoff B, Gentsch JR (1999) Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 17:2207–2222PubMedCrossRef

Kurugol Z, Geylani S, Karaca Y, Umay F, Erensoy S, Vardar F, Bak M, Yaprak I, Ozkinay F, Ozkinay C (2003) Rotavirus gastroenteritis among children under five years of age in Izmir, Turkey. Turk J Pediatr 45:290–294PubMed

Bresee JS, Parashar UD, Widdowson MA, Gentsch JR, Steele AD, Glass RI (2005) Update on rotavirus vaccines. Pediatr Infect Dis J 24:947–952PubMedCrossRef

Parashar UD, Glass RI (2006) Progress toward rotavirus vaccines. Science 312:851–852PubMedCrossRef

Parashar UD, Gibson CJ, Bresee JS, Glass RI (2006) Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12:304–306PubMed

Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI (2003) Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9:565–572PubMed

10.

Soriano-Gabarró M, Mrukowicz J, Vesikari T, Verstraeten T (2006) Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 25:S7–S11PubMedCrossRef

11.

Centers for Disease Control and Prevention (1998) Laboratory-based surveillance for rotavirus: United States, July 1997–June 1998. MMWR Morb Mortal Wkly Rep 47:978–980

12.

Brandt CD, Kim HW, Yolken RH, Kapikian AZ, Arrobio JO, Rodriguez WJ, Wyatt RG, Cahnock RM, Parrott RH (1979) Comparative epidemiology of two rotavirus serotypes and other viral agents associated with pediatric gastroenteritis. Am J Epidemiol 110:243–254PubMed

13.

Bishop RF, Barnes GL, Cipriani E, Lund JS (1983) Clinical immunity after neonatal rotavirus infection. N Engl J Med 309:72–76PubMedCrossRef

14.

American Academy of Pediatrics Committee on Infectious Diseases (2007) Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics 119:171–182CrossRef

15.

Ford T (2006) Emerging issues in water and health research. J Water Health 4(Suppl 1):59–65PubMed

16.

Sharma R, Hudak ML, Premachandra BR, Stevens G, Monteiro CB, Bradshaw JA, Kaunitz AM, Hollister RA (2002) Clinical manifestations of rotavirus infection in the neonatal intensive care unit. Pediatr Infect Dis 21:1099–1105CrossRef

17.

Newman RD, Grupp-Phelan J, Shay DK, Davis RL (1999) Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics 103:E3PubMedCrossRef

18.

Dennehy PH, Cortese MM, Beque RE, Jaeger JL, Roberts NE, Zhang R, Rhodes P, Gentsch J, Ward R, Bernstein DI, Vitek C, Bresee JS, Staat MA (2006) A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children. Pediatr Infect Dis J 25:1123–1131PubMedCrossRef

19.

Liakopoulou E, Nutton K, Carrington D, Robinson S, Steward CG, Goulden NJ, Cornish JM, Marks DI (2005) Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation. Bone Marrow Transplant 36:691–694PubMedCrossRef

20.

Saulsbury FT, Winkelstein JA, Yolken RH (1980) Chronic rotavirus infection in immunodeficiency. J Pediatr 97:61–65PubMedCrossRef

21.

Albano F, Bruzzese E, Bella A, Cascio A, Titone L, Arista S, Izzi G, Virdis R, Pecco P, Principi N, Fontana M, Guarino A (2007) Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study. Eur J Pediatr 166:241–247PubMedCrossRef

22.

Banerjee I, Ramani S, Primrose B, Moses P, Iturriza-Gomara M, Gray JJ, Jaffar S, Monica B, Muliyil JP, Brown DW, Estes MK, Kang G (2006) Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India. J Clin Microbiol 44:2468–2474PubMedCrossRef

23.

Gianino P, Mastretta E, Longo P, Laccisaglia A, Sartore M, Russo R, Mazzaccara A (2002) Incidence of nosocomial rotavirus infections, symptomatic and asymptomatic, in breast-fed and non-breast-fed infants. J Hosp Infect 50:13–17PubMedCrossRef

24.

Sterling LM, Richardson J, Ellis M (2003) Clinical inquiries. Does breastfeeding protect against viral GI infections in children <2 years old? J Fam Pract 52:805–806PubMed

25.

Greenberg HB, Clark HF, Offit PA (1994) Rotavirus pathology and pathophysiology. Curr Top Microbiol Immunol 185:255–283PubMed

26.

Raebel MA, Ou BS (1999) Rotavirus disease and its prevention in infants and children. Pharmacotherapy 19:1279–1295PubMedCrossRef

27.

Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM (1996) Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 335:1022–1028PubMedCrossRef

28.

RotaTeq (rotavirus vaccine, live, oral, pentavalent) (2007) Product information. Merck & Co., Inc., Whitehouse Station, NJ, USA

29.

RotaTeq (oral solution, rotavirus vaccine [live, oral]) (2007) Summary of product characteristics. Sanofi Pasteur MDS, SNC, Lyon, France

30.

Rotarix (powder and solvent for oral suspension) (2007) Summary of product characteristics. GlaxoSmithKline Biologicals s.a., Rixensart, Belgium

31.

Van Damme P on behalf of ESPID-ESPGHAN Rotavirus Expert Group (2007) Evidence-based recommendations for the use of rotavirus vaccines in Europe (abstract). Presented at the 25th Annual Meeting of the European Society for Paediatric Infectious Diseases, Porto, Portugal, 2–4 May

32.

Parashar UD, Alexander JP, Glass RI, Advisory Committee on Immunization Practices (ACIP) (2006) Prevention of rotavirus gastroenteritis among infants and children. Recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55(RR-12):1–13PubMed

33.

Parashar UD, Bresee JS, Gentsch JR, Glass RI (1998) Rotavirus. Emerg Infect Dis 4:561–570PubMedCrossRef

34.

Cook SM, Glass RI, LeBaron CW, Ho MS (1990) Global seasonality of rotavirus infections. Bull World Health Organ 68:171–177PubMed

35.

Sharma R, Garrison RD, Tepas III JJ, Mollitt DL, Pieper P, Hudak ML, Bradshaw JA, Stevens G, Premachandra BR (2004) Rotavirus-associated necrotizing enterocolitis: an insight into a potentially preventable disease? J Pediatr Surg 39:453–457PubMedCrossRef

36.

Troussard X, Bauduer F, Gallet E, Freymuth F, Boutard P, Ballet JJ, Reman O, Leporrier M (1993) Virus recovery from stools of patients undergoing bone marrow transplantation. Bone Marrow Transplant 12:573–576PubMed

37.

Yolken RH, Bishop CA, Townsend TR, Bolyard EA, Bartlett J, Santos GW, Saral R (1982) Infectious gastroenteritis in bone-marrow-transplant recipients. N Engl J Med 306:1010–1012PubMedCrossRef

38.

Centers for Disease Control and Prevention (2007) Advisory Committee on Immunization Practices. Record of the proceedings, 27–28 June

39.

Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Chrisite CDC, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O’Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM, Rotavirus Efficacy and Safety Trial (REST) Study Team (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23–33PubMedCrossRef

40.

Goveia MG, Rodriguez ZM, Dallas MJ, Itzler RF, Boslego JW, Heaton PM, DiNubile MJ, REST Study Team (2007) Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J 26:1099–1104PubMedCrossRef

41.

Jackson KM, Nazar AM (2006) Breastfeeding, the immune response, and long-term health. J Am Osteopath Assoc 106:203–207PubMed

42.

Greenberg DP, Vadheim CM, Partridge S, Chang SJ, Chiu CY, Ward JI (1994) Immunogenicity of Haemophilus influenzae type b tetanus toxoid conjugate vaccine in young infants. The Kaiser-UCLA Vaccine Study Group. J Infect Dis 170:76–81PubMed

43.

Pichichero ME (1990) Effect of breast-feeding on oral rhesus rotavirus vaccine seroconversion: a meta-analysis. J Infect Dis 162:753–755PubMed

Titel: Pentavalent human-bovine (WC3) reassortant rotavirus vaccine in special populations: a review of data from the Rotavirus Efficacy and Safety Trial
verfasst von: M. Van der Wielen
P. Van Damme
Publikationsdatum: 01.07.2008
Verlag: Springer-Verlag
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2008
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-008-0479-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2008

Minimum requirements for a rapid and reliable routine identification and antibiogram of Fusobacterium necrophorum

MRSA and the environment: implications for comprehensive control measures

Activities of artesunate and amodiaquine against intestinal helminth in children with Plasmodium falciparum malaria in endemic areas

Expression of a functional single-chain antibody via Corynebacterium pseudodiphtheriticum

Pyrosequencing™ analysis of the gyrB gene to differentiate bacteria responsible for diarrheal diseases